ISIS-3: a randomised comparison of streptokinase vs tissue plasminogen activator vs anistreplase and of aspirin plus heparin vs aspirin alone among 41 299 cases of suspected acute myocardial infarction

No abstract is available for this paper.

• Publication year

  1992

• Venue

  The Lancet

• Publication date

  1992-03-28

• Fields of study

  Medicine

• Identifiers
  DOI 10.1016/0140-6736(92)91893-D
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar

• No claims are published for this paper.

• No concepts are published for this paper.

• No references are available for this paper.

• Cholesterol crystal embolization syndrome: Systemic and end-organ injury

  2025cites this paper
• Evolving FATE: A New Lens on the Pathogenesis and Management of Feline Cardiogenic Arterial Thromboembolism

  2025cites this paper
• A Systematic Review of the Efficacy and Safety of Tenecteplase Versus Streptokinase in the Management of Myocardial Infarction in Developing Countries

  2023influential citation
• CONSISTENT COVARIANCES ESTIMATION FOR STRATUM IMBALANCES UNDER MARGINAL DESIGN FOR COVARIATE ADAPTIVE RANDOMIZATION

  2022cites this paper
• Production of fibrinolytic enzymes during food production

  2022cites this paper
• From Q/Non-Q Myocardial Infarction to STEMI/NSTEMI: Why It’s Time to Consider Another Simplified Dichotomy; a Narrative Literature Review

  2022cites this paper
• STEMI: A transitional fossil in MI classification?

  2021cites this paper
• Thrombolytic therapy use in peripheries of KPK

  2020cites this paper
• Designing, Conducting, Monitoring, and Analyzing Data from Pragmatic Randomized Clinical Trials: Proceedings from a Multi-stakeholder Think Tank Meeting

  2020cites this paper
• In memoriam: Peter Sleight 1929-2020.

  2020cites this paper
• Human Challenge Studies Are Unlikely to Accelerate Coronavirus Vaccine Licensure Due to Ethical and Practical Issues

  2020cites this paper
• Study of Adverse Events of Streptokinase Therapy in Patients with Acute ST Elevation Myocardial Infarction

  2020influential citation
• Purification, physicochemical properties, and statistical optimization of fibrinolytic enzymes especially from fermented foods: A comprehensive review.

  2020cites this paper
• 3 Ahmad Hasan.cdr

  2019cites this paper
• Fibrinolytic Enzymes for Thrombolytic Therapy.

  2019cites this paper
• Aspirin

  2019cites this paper
• Utilization trends in traditional Chinese medicine for acute myocardial infarction.

  2019cites this paper
• Bacterial staphylokinase as a promising third-generation drug in the treatment for vascular occlusion

  2019cites this paper
• Postmyocardial Infarction Cardiogenic Shock

  2019cites this paper
• Aspirin

  2019cites this paper
• Fibrinolysis: a Misunderstood Natural Defense Whose Therapeutic Potential Is Unknown

  2019cites this paper
• Translating the dose response into risk and benefit.

  2019cites this paper
• Thrombolysis: The Current State of The Art and How it can be Improved

  2019cites this paper
• Aspirin

  2019cites this paper
• Twenty-Five-Year (1986-2011) Trends in the Incidence and Death Rates of Stroke Complicating Acute Myocardial Infarction.

  2018cites this paper
• Fibrinolysis in Acute Myocardial Infarction ; State of the Art

  2018cites this paper
• The evolution of recombinant thrombolytics: Current status and future directions

  2017cites this paper
• Effect of thrombolytic therapy on the patterns of post myocardial infarction ventricular septal rupture

  2017cites this paper
• Long-Term Risk of Stroke in Myocardial Infarction Survivors: Thirty-Year Population-Based Cohort Study

  2016cites this paper
• Are Sex Differences in Outcomes of Patients with ACS from Observational Registries Similar to the Findings from Randomized Clinical Trials?

  2016cites this paper
• Streptokinase Response and its Adverse Drug Reactions in Acute Myocardial Infarction Among Different Age Groups at Sudan Heart Center , Khartoum-Sudan

  2016cites this paper
• Refining the Enrolment Process in Emergency Medicine Research.

  2016cites this paper
• A Randomized Trial of Intravenous Heparin in 12 (Anisoylated Plasminogen Streptokinas Complex) in Nuae Myocardial Infarction : The Duke Clinical Cardiology Study (_1J_CCS) I 11action With Activator University THE DUCCS GROUP*

  2016cites this paper
• Acute Myocardial Infarction Low Molecular Weight Heparin ( Dalteparin ) as Adjuvant Treatment to Thrombolysis in Acute Myocardial Infarction — A Pilot Study : Biochemical Markers in Acute Coronary Syndromes ( BIOMACS II )

  2016cites this paper
• Why so little progress in therapeutic thrombolysis? The current state of the art and prospects for improvement

  2015cites this paper
• All-cause mortality and use of antithrombotics within 90 days of discharge in acutely ill medical patients

  2015cites this paper
• Risk of Ischemic Stroke After an Acute Myocardial Infarction in Patients With Diabetes Mellitus

  2014cites this paper
• Risks and Benefits of Thrombolytic, Antiplatelet, and Anticoagulant Therapies for ST Segment Elevation Myocardial Infarction: Systematic Review

  2014cites this paper
• The Risk of Ischemic Stroke after an Acute Myocardial Infarction in Patients with Decreased Renal Function

  2014cites this paper
• 2013 ACCF/AHA Guideline for the Management of ST‐Elevation Myocardial Infarction: Executive Summary: A Report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines

  2013cites this paper
• Role of Antiplatelet Therapies in Preventing Atherothrombosis

  2013cites this paper
• Thrombolytiques

  2013cites this paper
• The left bundle-branch block puzzle in the 2013 ST-elevation myocardial infarction guideline: from falsely declaring emergency to denying reperfusion in a high-risk population. Are the Sgarbossa Criteria ready for prime time?

  2013cites this paper
• Medication, reperfusion therapy and survival in a community-based setting of hospitalised myocardial infarction

  2013cites this paper
• 2013 ACCF/AHA guideline for the management of ST-elevation myocardial infarction: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines.

  2013cites this paper
• Fibrinolytic Mechanisms of tPA, prouPA, Mutant prouPA and Their Implications for Therapeutic Thrombolysis

  2013cites this paper
• The Dark Side of Reperfusion

  2012cites this paper
• Danger ahead: watch out for indirect comparisons!

  2012cites this paper
• Necessity of Using Intermediate Outcomes to Proxy Long Term Effects

  2012cites this paper
• Myocardial infarction in the elderly.

  2011cites this paper
• A Critical Appraisal of the Evolution of ST Elevation Myocardial Infarction (STEMI) Therapy A Critical Appraisal of the Evolution of ST Elevation Myocardial Infarction (STEMI) Therapy and the Evidence Behind the Current Treatment Guidelines

  2011cites this paper
• Long-term Follow-up of Patients Undergoing Postconditioning During ST-Elevation Myocardial Infarction

  2011cites this paper
• Standardized endpoint definitions for transcatheter aortic valve implantation clinical trials: a consensus report from the Valve Academic Research Consortium

  2010cites this paper
• SOME STATISTICS IN BIOINFORMATICS

  2009cites this paper
• The joint effects of apolipoprotein B, apolipoprotein A1, LDL cholesterol, and HDL cholesterol on risk: 3510 cases of acute myocardial infarction and 9805 controls

  2009cites this paper
• Some statistics in bioinformatics: The fifth Armitage Lecture

  2009cites this paper
• Myocardial infarction (ST-elevation).

  2009cites this paper
• Consensus of the French Society of Gerontology and Geriatrics and the French Society of Cardiology for the management of coronary artery disease in older adults.

  2009cites this paper
• The role of fondaparinux as an adjunct to thrombolytic therapy in acute myocardial infarction: a subgroup analysis of the OASIS-6 trial.

  2008cites this paper
• Thrombolysis or nothing for acute myocardial infarction? It's all the same!

  2008cites this paper
• The cost-effectiveness of thrombolysis administered by paramedics*

  2008cites this paper
• Recent developments in acute coronary syndromes.

  2008cites this paper
• Clinical Practice Guidelines ( 8 th Edition ) College of Chest Physicians Evidence-Based and Thrombolytic Treatment : American Hemorrhagic Complications of Anticoagulant

  2008cites this paper
• Continuum of Care in the Treatment of ST-Segment Elevation Myocardial Infarction (STEMI): Importance of Platelet and Coagulation Inhibition

  2008cites this paper
• The cost-effectiveness of thrombolysis administered by paramedics.

  2008cites this paper
• Fibrinolytische Therapie

  2008cites this paper
• Causes of death in patients with acute myocardial infarction treated with angiotensin-converting enzyme inhibitors: findings from the Gruppo Italiano per lo Studio della Sopravvivenza nell'Infarto (GISSI)-3 trial.

  2008cites this paper
• Hemorrhagic complications of anticoagulant and thrombolytic treatment: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines (8th Edition).

  2008cites this paper
• Non-human primates: the appropriate subjects of biomedical research?

  2007cites this paper
• Acute Coronary Care in the Elderly, Part II: ST-Segment–Elevation Myocardial Infarction A Scientific Statement for Healthcare Professionals From the American Heart Association Council on Clinical Cardiology

  2007cites this paper
• Infarction : A Scientific Statement for Healthcare Professionals From the Acute Coronary Care in the Elderly , Part II : ST-Segment – Elevation Myocardial

  2007cites this paper
• Quality Indicators for the Care of Ischemic Heart Disease in Vulnerable Elders

  2007cites this paper
• Clinical Cardiology: New Frontiers Thrombolysis for Acute Myocardial Infarction

  2007cites this paper
• Akuter Myokardinfarkt mit persistierender ST-Elevation

  2006cites this paper
• Lymphotoxin-α Gene and Risk of Myocardial Infarction in 6,928 Cases and 2,712 Controls in the ISIS Case-Control Study

  2006cites this paper
• A pilot study on systemic thrombolysis followed by low molecular weight heparin in ischemic stroke

  2006cites this paper
• Low-Molecular-Weight Heparins in Conjunction with Thrombolysis for ST-Elevation Acute Myocardial Infarction

  2006cites this paper
• Chaîne de prise en charge de l'infarctus du myocarde en phase aiguë (syndrome coronaire aigu avec surélévation persistante du segment ST)

  2006cites this paper
• Post-thrombolysis intracerebral hemorrhage: Data from the Spanish Register ARIAM*

  2005cites this paper
• Fluid balance in acute lung injury: a model of clinical trial development.

  2005cites this paper
• Unfractionated and Low-Molecular-Weight Heparin as Adjuncts to Thrombolysis in Aspirin-Treated Patients With ST-Elevation Acute Myocardial Infarction: A Meta-Analysis of the Randomized Trials

  2005cites this paper
• Evidence-based Cardiology Reperfusion strategies in acute myocardial infarction

  2005cites this paper
• Evolving Role of Low-Molecular-Weight Heparins in ST-Elevation Myocardial Infarction

  2005cites this paper
• Large simple trials in psychiatry: providing reliable answers to important clinical questions

  2005cites this paper
• Acute myocardial infarction: pre-hospital and in-hospital management

  2005cites this paper
• Differentiating Pharmacologic Agents Used In Catheter-Directed Thrombolysis

  2005cites this paper
• Leitlinienkonforme Therapie des ST-Strecken-Hebungsinfarkts

  2005cites this paper
• Reflections on Ethical Concerns Arising from the Incorporation of Results of Randomized Trials of Antineoplastic Therapy into Routine Clinical Practice

  2005cites this paper
• Fibrinolytische Therapie

  2005cites this paper
• Lipid-related genes and myocardial infarction in 4685 cases and 3460 controls: discrepancies between genotype, blood lipid concentrations, and coronary disease risk.

  2004cites this paper
• Adjunctive treatment in patients treated with thrombolytic therapy

  2004cites this paper
• Aspirin

  2004cites this paper
• Time to treatment: A crucial factor in thrombolysis and primary angioplasty

  2004cites this paper
• Inhibition of Cardiac Mitochondrial Respiration by Salicylic Acid and Acetylsalicylate

  2004cites this paper
• Influences upon the diffusion of thrombolysis for acute myocardial infarction in England: Case study

  2004cites this paper
• Economics and quality of life after acute myocardial infarction: Insights from GUSTO-I

  2004cites this paper
• Where are clinical trials going? Society and clinical trials

  2004cites this paper
• Education and debate

  2004cites this paper
• Randomized clinical trials: Slow death by a thousand unnecessary policies?

  2004cites this paper
• Utility of a weight‐based heparin nomogram for patients with acute coronary syndromes

  2003cites this paper